Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

2.775 -0.025 (-0.89%)
Streaming Delayed Price Updated: 3:04 PM EDT, Oct 7, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,002,990
Open 2.750
Bid (Size) 2.770 (239)
Ask (Size) 2.780 (78)
Prev. Close 2.800
Today's Range 2.630 - 2.790
52wk Range 1.250 - 5.860
Shares Outstanding 283,162,902
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga

Performance

YTD
-20.03%
-20.03%
1 Month
+14.67%
+14.67%
3 Month
+8.40%
+8.40%
6 Month
+11.45%
+11.45%
1 Year
-50.80%
-50.80%

More News

Read More
Why Agenus Stock Rose 18.4% on Thursday
Via The Motley Fool
Short Volatility Alert: Agenus Inc.
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Agenus to Host “The Road Taken” R&D Event on November 12, 2022
From Agenus Inc.
Via Globe NewsWire
Recap: Agenus Q2 Earnings
Via Benzinga
Recap: Agenus Q1 Earnings
Via Benzinga
Agenus to Present Botensilimab Data at a Plenary Session of the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From Agenus Inc.
Via Globe NewsWire
7 Penny Stocks That Actually Have a Buy Rating
Via InvestorPlace
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate
Via Benzinga
Agenus Earnings Perspective: Return On Capital Employed
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Agenus Commences Initial-Stage Advanced Tumors Study
Via Benzinga
Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Via Benzinga
U.S. Stocks Turn Negative; 2U Shares Spike Higher
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Via Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Agenus Touts 'Unprecedented Activity' For Botensilimab/Balstilimab Combo In Colorectal Cancer
Via Benzinga
Agenus's Return On Capital Employed Insights
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Via Benzinga
Looking Into Agenus's Return On Capital Employed
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.